Skip to Main Content

Paper Details

Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC.
Neuropathol Appl Neurobiol
5
2022
-, ATRT, LGDIT, Low-grade diffusely infiltrative tumour, MYC, SMARCB1, low-grade lesion
Author NameAffiliation
Fausto J RodriguezThe Johns Hopkins University School of Medicine
Fausto J RodriguezThe Johns Hopkins University School of Medicine
Sylvia ChengUniversity of British Columbia
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center
Pascal D JohannHopp Children's Cancer Center (KiTZ)
Pascal D JohannSwabian Childrens' Cancer Center, University Childrens' Hospital Medical Center Augsburg and EU-RHAB Registry
Pascal D JohannGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Michael C FrühwaldSwabian Childrens' Cancer Center, University Childrens' Hospital Medical Center Augsburg and EU-RHAB Registry
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
  • 1 - 18

Datasets